Abstracts tagged "effective leader and rheumatoid arthritis (RA)"

Abstract Number: 2824 • 2014 ACR/ARHP Annual Meeting
A Profile of the Efficacy of Sarilumab Plus Methotrexate in Rheumatoid Arthritis Patients: Results of a 52-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study
Arthur Kavanaugh¹, Dennis L. Decktor², Chunpeng Fan³, Janet van Adelsberg², Renata Martincova⁴ and Mark C. Genovese⁵, ¹University of California San Diego, La Jolla, CA, ²Regeneron Pharmaceuticals, Inc., Tarrytown, NY, ³Biostatistics, Sanofi, Bridgewater, NJ, ⁴Sanofi Czech Republic, Prague, Czech Republic, ⁵Stanford University Medical Center, Palo Alto, CA
Background/Purpose Interleukin-6 (IL-6) regulates a diverse array of activities that may underlie systemic and local symptoms of rheumatoid arthritis (RA). The efficacy of sarilumab, a…